| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: Q4QGA3
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.654 |
| CLV_NRD_NRD_1 | 175 | 177 | PF00675 | 0.554 |
| CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.468 |
| CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.658 |
| CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.667 |
| CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.535 |
| CLV_PCSK_KEX2_1 | 247 | 249 | PF00082 | 0.663 |
| CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.453 |
| CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.639 |
| CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.523 |
| CLV_PCSK_PC1ET2_1 | 75 | 77 | PF00082 | 0.634 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.620 |
| DEG_SCF_FBW7_1 | 4 | 11 | PF00400 | 0.631 |
| DOC_CYCLIN_RxL_1 | 172 | 182 | PF00134 | 0.626 |
| DOC_CYCLIN_yCln2_LP_2 | 164 | 170 | PF00134 | 0.412 |
| DOC_MAPK_MEF2A_6 | 162 | 171 | PF00069 | 0.563 |
| DOC_MAPK_MEF2A_6 | 55 | 63 | PF00069 | 0.550 |
| DOC_MAPK_RevD_3 | 61 | 76 | PF00069 | 0.568 |
| DOC_PP1_RVXF_1 | 173 | 180 | PF00149 | 0.638 |
| DOC_PP2B_LxvP_1 | 236 | 239 | PF13499 | 0.665 |
| DOC_USP7_MATH_1 | 140 | 144 | PF00917 | 0.622 |
| DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.713 |
| DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.691 |
| DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.658 |
| DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.680 |
| LIG_14-3-3_CanoR_1 | 155 | 164 | PF00244 | 0.614 |
| LIG_14-3-3_CanoR_1 | 175 | 180 | PF00244 | 0.499 |
| LIG_BRCT_BRCA1_1 | 140 | 144 | PF00533 | 0.443 |
| LIG_FHA_1 | 105 | 111 | PF00498 | 0.662 |
| LIG_FHA_1 | 172 | 178 | PF00498 | 0.553 |
| LIG_FHA_1 | 186 | 192 | PF00498 | 0.575 |
| LIG_FHA_2 | 5 | 11 | PF00498 | 0.701 |
| LIG_FHA_2 | 98 | 104 | PF00498 | 0.650 |
| LIG_HP1_1 | 167 | 171 | PF01393 | 0.406 |
| LIG_IBAR_NPY_1 | 166 | 168 | PF08397 | 0.407 |
| LIG_Integrin_RGD_1 | 121 | 123 | PF01839 | 0.667 |
| LIG_LIR_Gen_1 | 165 | 172 | PF02991 | 0.415 |
| LIG_LIR_Gen_1 | 85 | 92 | PF02991 | 0.591 |
| LIG_LIR_Nem_3 | 165 | 171 | PF02991 | 0.412 |
| LIG_LIR_Nem_3 | 85 | 90 | PF02991 | 0.587 |
| LIG_NRP_CendR_1 | 247 | 249 | PF00754 | 0.719 |
| LIG_SH2_PTP2 | 135 | 138 | PF00017 | 0.555 |
| LIG_SH2_PTP2 | 168 | 171 | PF00017 | 0.413 |
| LIG_SH2_STAP1 | 30 | 34 | PF00017 | 0.497 |
| LIG_SH2_STAT3 | 34 | 37 | PF00017 | 0.585 |
| LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.622 |
| LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.413 |
| LIG_SH3_3 | 218 | 224 | PF00018 | 0.621 |
| LIG_SUMO_SIM_par_1 | 76 | 81 | PF11976 | 0.527 |
| LIG_TRAF2_1 | 100 | 103 | PF00917 | 0.656 |
| LIG_WRC_WIRS_1 | 192 | 197 | PF05994 | 0.524 |
| LIG_WW_3 | 237 | 241 | PF00397 | 0.535 |
| MOD_CK1_1 | 178 | 184 | PF00069 | 0.579 |
| MOD_CK1_1 | 194 | 200 | PF00069 | 0.389 |
| MOD_CK2_1 | 178 | 184 | PF00069 | 0.562 |
| MOD_CK2_1 | 4 | 10 | PF00069 | 0.770 |
| MOD_CK2_1 | 97 | 103 | PF00069 | 0.652 |
| MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.609 |
| MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.545 |
| MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.575 |
| MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.567 |
| MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.512 |
| MOD_GSK3_1 | 134 | 141 | PF00069 | 0.577 |
| MOD_GSK3_1 | 171 | 178 | PF00069 | 0.626 |
| MOD_GSK3_1 | 33 | 40 | PF00069 | 0.554 |
| MOD_GSK3_1 | 4 | 11 | PF00069 | 0.646 |
| MOD_GSK3_1 | 41 | 48 | PF00069 | 0.656 |
| MOD_GSK3_1 | 78 | 85 | PF00069 | 0.548 |
| MOD_GSK3_1 | 88 | 95 | PF00069 | 0.651 |
| MOD_N-GLC_1 | 88 | 93 | PF02516 | 0.561 |
| MOD_NEK2_1 | 171 | 176 | PF00069 | 0.693 |
| MOD_NEK2_1 | 63 | 68 | PF00069 | 0.615 |
| MOD_NEK2_2 | 104 | 109 | PF00069 | 0.592 |
| MOD_PIKK_1 | 33 | 39 | PF00454 | 0.652 |
| MOD_PKA_1 | 175 | 181 | PF00069 | 0.556 |
| MOD_PKA_1 | 32 | 38 | PF00069 | 0.669 |
| MOD_PKA_1 | 41 | 47 | PF00069 | 0.688 |
| MOD_PKA_2 | 175 | 181 | PF00069 | 0.557 |
| MOD_PKA_2 | 239 | 245 | PF00069 | 0.553 |
| MOD_PKA_2 | 32 | 38 | PF00069 | 0.644 |
| MOD_PKA_2 | 41 | 47 | PF00069 | 0.678 |
| MOD_PKA_2 | 92 | 98 | PF00069 | 0.673 |
| MOD_Plk_4 | 191 | 197 | PF00069 | 0.573 |
| MOD_Plk_4 | 25 | 31 | PF00069 | 0.519 |
| MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.664 |
| MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.677 |
| TRG_ENDOCYTIC_2 | 168 | 171 | PF00928 | 0.413 |
| TRG_ER_diArg_1 | 175 | 177 | PF00400 | 0.645 |
| TRG_ER_diArg_1 | 247 | 249 | PF00400 | 0.659 |
| TRG_ER_diArg_1 | 32 | 34 | PF00400 | 0.547 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P8Q3 | Leptomonas seymouri | 57% | 85% |
| A0A1X0NN61 | Trypanosomatidae | 36% | 100% |
| A0A3S5H6N4 | Leishmania donovani | 93% | 100% |
| A0A422NQK2 | Trypanosoma rangeli | 33% | 100% |
| A4H740 | Leishmania braziliensis | 79% | 84% |
| A4HVI0 | Leishmania infantum | 92% | 100% |
| D0A6T1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
| E9AP75 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
| V5AVG9 | Trypanosoma cruzi | 37% | 86% |